ASTROCYTOMA
Clinical trials for ASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new ASTROCYTOMA trials appear
Sign up with your email to follow new studies for ASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental brain tumor combo shows promise but trial halted early
Disease control TerminatedThis study tested a new drug called zotiraciclib (TG02) combined with the standard chemotherapy temozolomide in adults with recurrent anaplastic astrocytoma or glioblastoma. The goal was to find the safest dose and see if the combination worked better than temozolomide alone. The…
Matched conditions: ASTROCYTOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Antifungal drug tested against brain tumors – trial stopped early
Knowledge-focused TerminatedThis early-phase trial tested whether the antifungal drug ketoconazole could block a protein called tGLI1 in brain tumors. It included 15 people with breast cancer that spread to the brain or with a type of brain cancer called glioma. The study was terminated early, so we have li…
Matched conditions: ASTROCYTOMA
Phase: EARLY_PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Brain tumor study looks at tiny molecule as possible clue
Knowledge-focused TerminatedThis study looked at a tiny molecule called microRNA-10b in people with brain tumors called gliomas. Researchers wanted to see if higher levels of this molecule could help predict how the disease might progress or how long patients might live. The study was stopped early, but it …
Matched conditions: ASTROCYTOMA
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:16 UTC